Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,056.80
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.77
(
-0.43%
)
Bitcoin
77,758.06
(
-0.66%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: si39 post# 233842

Friday, 07/24/2020 12:09:27 PM

Friday, July 24, 2020 12:09:27 PM

Post# of 257442

MRNA may have to invalidate ABUS patents on appeal to get around not paying license fees on its own mRNA vaccine.

The royalty MRNA may be required to pay to license the ABUS patents in question is likely in the single-digit range, which is consistent with MRNA’s price action today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today